Scientists were able to slow down MS progression in a new clinical trial using stem cell transplantation. Multiple sclerosis (MS) is…
AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA)…
The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma…
Results from a late-stage study showed MacroGenics’ experimental drug margetuximab extended progression-free survival in previously treated HER-2 positive metastatic breast cancer patients…
PARIS and TARRYTOWN, NY – February 4, 2019 – The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP)…
Following Biogen’s Q4 and full year 2018 earnings call (29 January), Antoine Grey, Pharma Analyst at GlobalData, a leading data and…
Culture unmasked at the best and worst performing NHS hospital trusts Tuesday 5th February: A new report published today by Pulse UK,…
Study evaluated the benefit of isatuximab in combination with standard of care in prolonging progression free survival as compared to…
AMSTERDAM, The Netherlands, February 05, 2019 / B3C newswire / — The REGAIN consortium, led by Audion Therapeutics BV, a company dedicated to the…
Plymouth Meeting, PA – February 6, 2019: CRF Bracket is celebrating unprecedented success in Romania after opening an eClinical technology facility…
